I-Tech AB (publ) (ticker: ITECH) publish the interim report for the second quarter 2020

” Continued growth and positive development despite shipping headwinds ”

Net turnover for the period amounted to kSEK 16,150 (12,582), corresponding to an increase in turnover of 28% (36%). Operating profit/loss amounted to kSEK 47 (-906).

Net sales for the first half of the year amounted to kSEK 29 675 (18 752), corresponding to an increase in sales of 58% (43%). 

Operating result amounted to kSEK -937 (-5 341).

April to June 2020

• I-Tech renewed and upgraded the regulatory status of Selektope® in Japan.

• At the Annual General Meeting, Chatarina Schneider and Tomas Bergdahl were elected as new board members, replacing Leif Darner and Mats Enegren.

• The ongoing COVID-19 pandemic has reduced the demand for freight worldwide as a consequence of strict lockdowns in several places. This has had a negative impact on shipping. The development of the pandemic in India is of particular importance for I-Tech’s production. Looking forward, the situation is difficult to predict but, so far, the direct impact on I-Tech has been limited to higher logistics costs.

Important events after the period

• No important events have occurred after the period.

Financial Summary
 

CEO comments 
 

In the waves of continued declining global demand for sea freight, and subsequent overcapacity and restraint, I-Tech reports continued growth, albeit at slightly lower levels than in previous quarters. Sales for the quarter amounted to SEK 16.2 million (12.6 million) and operating profit was SEK 0.0 million (-0.9 million). One reason is that the market for Selektope®-based anti-fouling products grew during the quarter at a faster pace than the market for traditional products. This is related to better performance and environmental benefits. 

Above all, a continued strong development for Chugoku Marine Paints (CMP) lies behind the sales growth during the quarter. With its Selektope® products, CMP has strengthened its position, not least on the maintenance side (dry-docking), in several significant markets.

Paradoxically, one reason for this is the COVID-19 pandemic, which has continued to leave its mark on the business climate during the quarter, and which has led to a reduced demand for shipping and an increase in stationary ships. This has resulted in longer idling times for the ships, with a consequent risk of increased biofouling, as well as increased financial uncertainty for the shipowners. For shipowners and operators who are still willing to invest, the pandemic has highlighted the importance of using the best possible protection to handle longer periods of idling. CMP has benefited here from its long experience and its good position on the market, as well as being able to offer Selektope® -based products that meet customer requirements for performance and durability. As a result, CMP’s collaborations and deals with well-known shipowners have increased, and their Selektope® -based products have taken an increasing share of the market as customers see the benefits they offer.

For I-Tech, there is a risk that the increased uncertainty in the wake of the pandemic and the strengthened Swedish krona will have some impact on growth and profitability for some time yet.

In the operational part of the company, we have started to deliver material from a second fully qualified supplier, which has safeguarded production flows and provided increased security. Although we have seen a positive development when it comes to the implementation of process improvements, and thereby a slightly lower purchase price, we still have higher logistical costs than normal. This means that our gross profit remains at approximately the same level as last year at 47 % (45).

During the quarter, I-Tech also received a renewed and upgraded regulatory status in Japan. This eliminates a number of bureaucratic obstacles for our customers’ sales of Selektope®-based products and creates more favourable conditions for them to import larger volumes. As a result, the prerequisites are improved to support for an increased activity in Japan moving forward.

We have also received a new order from our, earlier communicated and yet unnamed, non-Scandinavian customer, worth approximately a quarter of a million US dollars. The order will be delivered during the third quarter. The customer focuses on the new construction market in Northeast Asia, which is a positive signal that new construction projects have not been paused excessively.

When I summarise the first half of the year, I note that it has been challenging for I-Tech, but we have proven during this period that we have an attractive product that can grow even under difficult market conditions. I also see our good exposure towards strong Asian markets and the generally growing interest for more sustainable solutions. All in all, it provides good indications of the Selektope®-based products’ commercial potential in a more normal business climate.

Philip Chaabane, CEO

M: +46 73 910 37 08
E: 

ph*************@i-****.se

This information is information that I-Tech AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, at 08:00 CET on August 26, 2020.

About I-Tech AB

 I-Tech is a biotechnology company that has developed the product Selektope®, an active agent that prevents barnacle attachment on submerged surfaces such as ships and boat hulls, but also other marine installations. By increasing the resistance to barnacle growth in marine paint systems (e.g. antifouling coatings), fuel and maintenance costs are reduced. I-Tech has obtained the necessary regulatory approvals for Selektope® and has several of the world's largest manufacturers of marine antifouling coatings as customers. The company's share is listed for trading on Nasdaq First North Growth Market in Stockholm with Erik Penser Bank as Certified Adviser, phone: +46 (0)8 463 83 00, email: 

ce**************@pe****.se











. For more information visit our website www.i-tech.se.

About Selektope®

Selektope® introduces, for the first time, a pharmacological mode of action to combat barnacle settlement. By temporarily stimulating the octopamine receptor, the barnacle larvae’s swimming behavior is activated and the organisms are deterred from the hull. These ground-breaking discoveries enable unrivalled power at very low concentrations, yet within the limits of rigorous risk assessments. Selektope® is an organic, non-metal compound with efficacy proven at 0.1% w/w. For more information visit our website www.selektope.com

Release